Click for best price
Endometrial Cancer Market Size, Share 2023
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to Others parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Others symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.
This report aims to provide a comprehensive presentation of the global market for Endometrial Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endometrial Cancer. This report contains market size and forecasts of Endometrial Cancer in global, including the following market information:
Global Endometrial Cancer Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Endometrial Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The endometrial cancer market is dominated by North America owing to the rising prevalence of breast cancer.
We surveyed the Endometrial Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endometrial Cancer Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Endometrial Cancer Market Segment Percentages, by Type, 2022 (%)
Hysterectomy Techniques
Radiation
Hormone Therapy
ChemOthersapy
Global Endometrial Cancer Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Endometrial Cancer Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Gynecology Centers
Others
Global Endometrial Cancer Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Endometrial Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endometrial Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Endometrial Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Boston Scientific
GE
Karl Storz
Koninklijke Philips
Celgene
Lupin
LiNA Medical
Bayer AG
Cooper Surgical
Hologic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Endometrial Cancer, market overview.
Chapter 2: Global Endometrial Cancer market size in revenue.
Chapter 3: Detailed analysis of Endometrial Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endometrial Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Endometrial Cancer Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Endometrial Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endometrial Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endometrial Cancer Overall Market Size
2.1 Global Endometrial Cancer Market Size: 2022 VS 2030
2.2 Global Endometrial Cancer Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Endometrial Cancer Players in Global Market
3.2 Top Global Endometrial Cancer Companies Ranked by Revenue
3.3 Global Endometrial Cancer Revenue by Companies
3.4 Top 3 and Top 5 Endometrial Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Endometrial Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endometrial Cancer Players in Global Market
3.6.1 List of Global Tier 1 Endometrial Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Endometrial Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Endometrial Cancer Market Size Markets, 2022 & 2030
4.1.2 Hysterectomy Techniques
4.1.3 Radiation
4.1.4 Hormone Therapy
4.1.5 ChemOthersapy
4.2 By Type - Global Endometrial Cancer Revenue & Forecasts
4.2.1 By Type - Global Endometrial Cancer Revenue, 2018-2023
4.2.2 By Type - Global Endometrial Cancer Revenue, 2024-2030
4.2.3 By Type - Global Endometrial Cancer Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endometrial Cancer Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Gynecology Centers
5.1.5 Others
5.2 By Application - Global Endometrial Cancer Revenue & Forecasts
5.2.1 By Application - Global Endometrial Cancer Revenue, 2018-2023
5.2.2 By Application - Global Endometrial Cancer Revenue, 2024-2030
5.2.3 By Application - Global Endometrial Cancer Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Endometrial Cancer Market Size, 2022 & 2030
6.2 By Region - Global Endometrial Cancer Revenue & Forecasts
6.2.1 By Region - Global Endometrial Cancer Revenue, 2018-2023
6.2.2 By Region - Global Endometrial Cancer Revenue, 2024-2030
6.2.3 By Region - Global Endometrial Cancer Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Endometrial Cancer Revenue, 2018-2030
6.3.2 US Endometrial Cancer Market Size, 2018-2030
6.3.3 Canada Endometrial Cancer Market Size, 2018-2030
6.3.4 Mexico Endometrial Cancer Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Endometrial Cancer Revenue, 2018-2030
6.4.2 Germany Endometrial Cancer Market Size, 2018-2030
6.4.3 France Endometrial Cancer Market Size, 2018-2030
6.4.4 U.K. Endometrial Cancer Market Size, 2018-2030
6.4.5 Italy Endometrial Cancer Market Size, 2018-2030
6.4.6 Russia Endometrial Cancer Market Size, 2018-2030
6.4.7 Nordic Countries Endometrial Cancer Market Size, 2018-2030
6.4.8 Benelux Endometrial Cancer Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Endometrial Cancer Revenue, 2018-2030
6.5.2 China Endometrial Cancer Market Size, 2018-2030
6.5.3 Japan Endometrial Cancer Market Size, 2018-2030
6.5.4 South Korea Endometrial Cancer Market Size, 2018-2030
6.5.5 Southeast Asia Endometrial Cancer Market Size, 2018-2030
6.5.6 India Endometrial Cancer Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Endometrial Cancer Revenue, 2018-2030
6.6.2 Brazil Endometrial Cancer Market Size, 2018-2030
6.6.3 Argentina Endometrial Cancer Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Endometrial Cancer Revenue, 2018-2030
6.7.2 Turkey Endometrial Cancer Market Size, 2018-2030
6.7.3 Israel Endometrial Cancer Market Size, 2018-2030
6.7.4 Saudi Arabia Endometrial Cancer Market Size, 2018-2030
6.7.5 UAE Endometrial Cancer Market Size, 2018-2030
7 Endometrial Cancer Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Endometrial Cancer Major Product Offerings
7.1.4 Pfizer Endometrial Cancer Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Endometrial Cancer Major Product Offerings
7.2.4 Johnson & Johnson Endometrial Cancer Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Boston Scientific
7.3.1 Boston Scientific Company Summary
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Endometrial Cancer Major Product Offerings
7.3.4 Boston Scientific Endometrial Cancer Revenue in Global Market (2018-2023)
7.3.5 Boston Scientific Key News & Latest Developments
7.4 GE
7.4.1 GE Company Summary
7.4.2 GE Business Overview
7.4.3 GE Endometrial Cancer Major Product Offerings
7.4.4 GE Endometrial Cancer Revenue in Global Market (2018-2023)
7.4.5 GE Key News & Latest Developments
7.5 Karl Storz
7.5.1 Karl Storz Company Summary
7.5.2 Karl Storz Business Overview
7.5.3 Karl Storz Endometrial Cancer Major Product Offerings
7.5.4 Karl Storz Endometrial Cancer Revenue in Global Market (2018-2023)
7.5.5 Karl Storz Key News & Latest Developments
7.6 Koninklijke Philips
7.6.1 Koninklijke Philips Company Summary
7.6.2 Koninklijke Philips Business Overview
7.6.3 Koninklijke Philips Endometrial Cancer Major Product Offerings
7.6.4 Koninklijke Philips Endometrial Cancer Revenue in Global Market (2018-2023)
7.6.5 Koninklijke Philips Key News & Latest Developments
7.7 Celgene
7.7.1 Celgene Company Summary
7.7.2 Celgene Business Overview
7.7.3 Celgene Endometrial Cancer Major Product Offerings
7.7.4 Celgene Endometrial Cancer Revenue in Global Market (2018-2023)
7.7.5 Celgene Key News & Latest Developments
7.8 Lupin
7.8.1 Lupin Company Summary
7.8.2 Lupin Business Overview
7.8.3 Lupin Endometrial Cancer Major Product Offerings
7.8.4 Lupin Endometrial Cancer Revenue in Global Market (2018-2023)
7.8.5 Lupin Key News & Latest Developments
7.9 LiNA Medical
7.9.1 LiNA Medical Company Summary
7.9.2 LiNA Medical Business Overview
7.9.3 LiNA Medical Endometrial Cancer Major Product Offerings
7.9.4 LiNA Medical Endometrial Cancer Revenue in Global Market (2018-2023)
7.9.5 LiNA Medical Key News & Latest Developments
7.10 Bayer AG
7.10.1 Bayer AG Company Summary
7.10.2 Bayer AG Business Overview
7.10.3 Bayer AG Endometrial Cancer Major Product Offerings
7.10.4 Bayer AG Endometrial Cancer Revenue in Global Market (2018-2023)
7.10.5 Bayer AG Key News & Latest Developments
7.11 Cooper Surgical
7.11.1 Cooper Surgical Company Summary
7.11.2 Cooper Surgical Business Overview
7.11.3 Cooper Surgical Endometrial Cancer Major Product Offerings
7.11.4 Cooper Surgical Endometrial Cancer Revenue in Global Market (2018-2023)
7.11.5 Cooper Surgical Key News & Latest Developments
7.12 Hologic
7.12.1 Hologic Company Summary
7.12.2 Hologic Business Overview
7.12.3 Hologic Endometrial Cancer Major Product Offerings
7.12.4 Hologic Endometrial Cancer Revenue in Global Market (2018-2023)
7.12.5 Hologic Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Endometrial Cancer Market Opportunities & Trends in Global Market
Table 2. Endometrial Cancer Market Drivers in Global Market
Table 3. Endometrial Cancer Market Restraints in Global Market
Table 4. Key Players of Endometrial Cancer in Global Market
Table 5. Top Endometrial Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Endometrial Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Endometrial Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Endometrial Cancer Product Type
Table 9. List of Global Tier 1 Endometrial Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endometrial Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Endometrial Cancer Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Endometrial Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Endometrial Cancer Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Endometrial Cancer Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Endometrial Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Endometrial Cancer Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Endometrial Cancer Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Endometrial Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Endometrial Cancer Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Endometrial Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Endometrial Cancer Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Endometrial Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Endometrial Cancer Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Endometrial Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Endometrial Cancer Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Endometrial Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Endometrial Cancer Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Endometrial Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Endometrial Cancer Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Endometrial Cancer Product Offerings
Table 32. Pfizer Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Endometrial Cancer Product Offerings
Table 36. Johnson & Johnson Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Boston Scientific Company Summary
Table 39. Boston Scientific Endometrial Cancer Product Offerings
Table 40. Boston Scientific Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Boston Scientific Key News & Latest Developments
Table 42. GE Company Summary
Table 43. GE Endometrial Cancer Product Offerings
Table 44. GE Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. GE Key News & Latest Developments
Table 46. Karl Storz Company Summary
Table 47. Karl Storz Endometrial Cancer Product Offerings
Table 48. Karl Storz Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Karl Storz Key News & Latest Developments
Table 50. Koninklijke Philips Company Summary
Table 51. Koninklijke Philips Endometrial Cancer Product Offerings
Table 52. Koninklijke Philips Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Koninklijke Philips Key News & Latest Developments
Table 54. Celgene Company Summary
Table 55. Celgene Endometrial Cancer Product Offerings
Table 56. Celgene Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Celgene Key News & Latest Developments
Table 58. Lupin Company Summary
Table 59. Lupin Endometrial Cancer Product Offerings
Table 60. Lupin Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Lupin Key News & Latest Developments
Table 62. LiNA Medical Company Summary
Table 63. LiNA Medical Endometrial Cancer Product Offerings
Table 64. LiNA Medical Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. LiNA Medical Key News & Latest Developments
Table 66. Bayer AG Company Summary
Table 67. Bayer AG Endometrial Cancer Product Offerings
Table 68. Bayer AG Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. Bayer AG Key News & Latest Developments
Table 70. Cooper Surgical Company Summary
Table 71. Cooper Surgical Endometrial Cancer Product Offerings
Table 72. Cooper Surgical Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 73. Cooper Surgical Key News & Latest Developments
Table 74. Hologic Company Summary
Table 75. Hologic Endometrial Cancer Product Offerings
Table 76. Hologic Endometrial Cancer Revenue (US$, Mn) & (2018-2023)
Table 77. Hologic Key News & Latest Developments
List of Figures
Figure 1. Endometrial Cancer Segment by Type in 2022
Figure 2. Endometrial Cancer Segment by Application in 2022
Figure 3. Global Endometrial Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Endometrial Cancer Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Endometrial Cancer Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Endometrial Cancer Revenue in 2022
Figure 8. By Type - Global Endometrial Cancer Revenue Market Share, 2018-2030
Figure 9. By Application - Global Endometrial Cancer Revenue Market Share, 2018-2030
Figure 10. By Type - Global Endometrial Cancer Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Endometrial Cancer Revenue Market Share, 2018-2030
Figure 12. By Application - Global Endometrial Cancer Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Endometrial Cancer Revenue Market Share, 2018-2030
Figure 14. By Region - Global Endometrial Cancer Revenue Market Share, 2018-2030
Figure 15. By Country - North America Endometrial Cancer Revenue Market Share, 2018-2030
Figure 16. US Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Endometrial Cancer Revenue Market Share, 2018-2030
Figure 20. Germany Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 21. France Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Endometrial Cancer Revenue Market Share, 2018-2030
Figure 28. China Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 32. India Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Endometrial Cancer Revenue Market Share, 2018-2030
Figure 34. Brazil Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Endometrial Cancer Revenue Market Share, 2018-2030
Figure 37. Turkey Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Endometrial Cancer Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boston Scientific Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GE Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Karl Storz Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Koninklijke Philips Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Celgene Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lupin Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. LiNA Medical Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bayer AG Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cooper Surgical Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Hologic Endometrial Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
